Zidesamtinib (NVL-520) is a macrocyclic ROS1 inhibitor that presents an interesting retrosynthetic challenge. Explore two proposed synthetic routes using ChemAIRS®, comparing fragment assembly, stereocenter formation, macrocyclization strategy, and route length.